WeVote
Log In

Bill

Bill

SB 503

PROHIBIT CERTAIN PHARMACY BENEFITS MGR. ACTS

2025 Regular Session Introduced by Larry Scott

New Mexico bill would restrict pharmacy benefit manager practices to protect patient medication access and pharmacy financial stability, though specific prohibitions remain undefined in available summaries.

action postponed indefinitely
#business&industry #health&healthfacilities
0
WeVote Research Nonpartisan
Bill Summary · SB 503

Legislative bill overview

SB 503 would prohibit pharmacy benefit managers (PBMs) from engaging in certain specified practices within New Mexico. The bill targets business conduct deemed harmful to patients and pharmacies, though the specific prohibited acts are not detailed in the publicly available summary provided.

Why is this important

PBMs act as intermediaries between insurers, pharmacies, and patients, controlling drug formularies and pricing. Restrictions on PBM practices directly affect medication affordability and access for New Mexico residents, as well as the financial viability of independent and small-chain pharmacies struggling under current reimbursement models.

Potential points of contention

  • Definition clarity: The bill's effectiveness depends entirely on precisely defining which PBM practices are prohibited; vague language could create enforcement challenges or be subject to legal challenges
  • Insurance cost impact: Restricting PBM practices could increase insurance premiums if cost-control mechanisms are limited, or conversely, could lower them if anti-competitive practices are eliminated
  • Market consolidation: PBMs argue restrictions could reduce competition and innovation, while advocates argue current consolidation already limits competition and harms patients and independent pharmacies

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.